Literature DB >> 10908609

Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

J L Mason1, P Ye, K Suzuki, A J D'Ercole, G K Matsushima.   

Abstract

Metabolic insult results in apoptosis and depletion of mature oligodendrocytes during demyelination. To examine the role of insulin-like growth factor-1 (IGF-1) during acute demyelination and remyelination in the adult CNS, we exposed transgenic mice that continuously express IGF-1 (IGF-1 tg) to cuprizone intoxication. Demyelination was observed within the corpus callosum in both wild-type and IGF-1 tg mice 3 weeks after exposure to cuprizone. Wild-type mice showed significant apoptotic mature oligodendrocytes and a dramatic loss of these cells within the lesion that resulted in near complete depletion and demyelination by week 5. In contrast, the demyelinated corpus callosum of the IGF-1 tg mice was near full recovery by week 5. This rapid recovery was apparently caused by survival of the mature oligodendrocyte population because apoptosis was negligible, and by week 4, the mature oligodendrocyte population was completely restored. Furthermore, despite demyelination in both wild-type and IGF-1 tg mice, oligodendrocyte progenitors accumulated only in the absence of mature oligodendrocytes and failed to accumulate if the mature oligodendrocytes remained as demonstrated in the IGF-1 tg mice. These results suggest that IGF-1 may be important in preventing the depletion of mature oligodendrocytes in vivo and thus facilitates an early recovery from demyelination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908609      PMCID: PMC6772563     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  24 in total

Review 1.  The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion.

Authors:  C S Raine
Journal:  J Neuroimmunol       Date:  1997-08       Impact factor: 3.478

2.  Remyelination of the central nervous system.

Authors:  A Compston
Journal:  Mult Scler       Date:  1996-07       Impact factor: 6.312

3.  Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture.

Authors:  K H Cho; M W Kim; S U Kim
Journal:  Dev Neurosci       Date:  1997       Impact factor: 2.984

4.  Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury.

Authors:  P Ye; A J D'Ercole
Journal:  Endocrinology       Date:  1999-07       Impact factor: 4.736

5.  Apoptosis in the nervous system in experimental allergic encephalomyelitis.

Authors:  M P Pender; K B Nguyen; P A McCombe; J F Kerr
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

6.  Endogenous progenitors remyelinate demyelinated axons in the adult CNS.

Authors:  J M Gensert; J E Goldman
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

7.  Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.

Authors:  T Coetzee; N Fujita; J Dupree; R Shi; A Blight; K Suzuki; K Suzuki; B Popko
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

8.  In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice.

Authors:  P Ye; J Carson; A J D'Ercole
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

9.  Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice.

Authors:  A Kondo; T Nakano; K Suzuki
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

10.  Multiple extracellular signals are required for long-term oligodendrocyte survival.

Authors:  B A Barres; R Schmid; M Sendnter; M C Raff
Journal:  Development       Date:  1993-05       Impact factor: 6.868

View more
  75 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.

Authors:  Ping Ye; Qichen Hu; Hedi Liu; Yun Yan; A Joseph D'ercole
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

3.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

Review 4.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

5.  IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.

Authors:  Julian Zimmermann; Michael Emrich; Marius Krauthausen; Simon Saxe; Louisa Nitsch; Michael T Heneka; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

6.  Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone.

Authors:  Handi Zhang; Yanbo Zhang; Haiyun Xu; Lingyan Wang; Jinsong Zhao; Junhui Wang; Zhijun Zhang; Qingrong Tan; Jiming Kong; Qingjun Huang; Xin-Min Li
Journal:  Neurosci Bull       Date:  2013-08-29       Impact factor: 5.203

7.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

Review 9.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

10.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.